 <h1>Nebivolol Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>More frequently reported side effects include:</b> fatigue.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nebivolol: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nebivolol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nebivolol:</p><p>
<i>Less common</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>chest pain or discomfort</li>
<li>difficult or labored breathing</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>rapid weight gain</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>wheezing</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking nebivolol:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Absence of or decrease in body movement</li>
<li>anxiety</li>
<li>blue lips, fingernails, or skin</li>
<li>blurred vision</li>
<li>chills</li>
<li>cold sweats</li>
<li>coma</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>cough</li>
<li>decreased urine output</li>
<li>depression</li>
<li>dilated neck veins</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>extreme fatigue</li>
<li>fast heartbeat</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased sweating</li>
<li>increased thirst</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>loss of appetite</li>
<li>mood changes</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>nervousness</li>
<li>nightmares</li>
<li>noisy breathing</li>
<li>numbness in the hands, feet, or lips</li>
<li>seizures</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>troubled breathing</li>
<li>vomiting</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nebivolol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Mild headache</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
<li>rash</li>
<li>sleeplessness</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nebivolol: oral tablet</i></p><h3>General</h3><p>The more frequently reported side effects in patients treated for hypertension were headache, dizziness, and fatigue; additionally, bradycardia was frequently reported in patients treated for chronic heart failure.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Bradycardia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Cardiac failure aggravation, edema, postural hypotension, first degree atrioventricular (AV) block, atrial fibrillation, hypertension, angina pectoris, chest pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Heart failure, slowed AV conduction, AV block (both second and third degree), hypotension, increased intermittent claudication, edema of the lower limbs, </p>
<p><b>Postmarketing reports</b>: Raynaud's phenomenon, myocardial infarction, peripheral ischemia<sup>[Ref]</sup></p><p>Bradycardia was a dose-related effect in hypertensive patients.  Bradycardia occurred more frequently in chronic heart failure patients (11%) than hypertensive patients (1%) at doses of 20 to 40 mg.</p>
<p></p>
<p>Aggravation of cardiac failure occurred in 19% of patients with chronic heart failure compared to 21.3% of placebo-treated patients in the SENIORS (Study on the Effects of Nebivolol Interventions on Outcomes and Rehospitalizations in Seniors with heart failure; n = 2128; median age = 75.2 years).  Heart failure occurred in 0.1% to 1% of hypertensive patients.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Headache, paresthesia, somnolence, hypoesthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Vertigo</p>
<p><b>Very rare</b> (less than 0.01%): Syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, exacerbated dyspnea, common cold, coughing, bronchitis, pharyngitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p>
<p><b>Postmarketing reports</b>: Acute pulmonary edema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Increased sweating</p>
<p><b>Uncommon</b> (0.1% to 1%): Pruritus, erythematous rash</p>
<p><b>Very rare</b> (less than 0.01%): Psoriasis aggravated </p>
<p><b>Frequency not reported</b>: Angioneurotic edema, urticaria</p>
<p><b>Postmarketing reports</b>: Rash, skin disorders<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, arthrosis, back pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, diarrhea, nausea </p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, flatulence, vomiting </p>
<p><b>Frequency not reported</b>: Abdominal pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tiredness, drug intolerance, pain, injury, fatigue</p>
<p><b>Frequency not reported</b>: Asthenia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness </p>
<p><b>Uncommon</b> (0.1% to 1%): Nightmares, depression, insomnia, anxiety<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Impotence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Impaired vision<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Decreased platelet count</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Increased BUN</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hypercholesterolemia, hyperuricemia, increased uric acid, increased triglycerides, decreased HDL cholesterol<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal hepatic function (e.g., increased AST, ALT, and bilirubin)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity (e.g., allergic vasculitis, angioedema, urticaria)<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Bystolic (nebivolol)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about nebivolol</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>221 Reviews</li>
<li>Drug class: cardioselective beta blockers</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nebivolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Bystolic</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
<li>Mitral Valve Prolapse</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nebivolol: oral tablet</i></p><h3>General</h3><p>The more frequently reported side effects in patients treated for hypertension were headache, dizziness, and fatigue; additionally, bradycardia was frequently reported in patients treated for chronic heart failure.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Bradycardia (up to 11%)</p><p><b>Common</b> (1% to 10%): Cardiac failure aggravation, edema, postural hypotension, first degree atrioventricular (AV) block, atrial fibrillation, hypertension, angina pectoris, chest pain</p><p><b>Uncommon</b> (0.1% to 1%): Heart failure, slowed AV conduction, AV block (both second and third degree), hypotension, increased intermittent claudication, edema of the lower limbs, </p><p><b>Postmarketing reports</b>: Raynaud's phenomenon, myocardial infarction, peripheral ischemia<sup>[Ref]</sup></p><p>Bradycardia was a dose-related effect in hypertensive patients.  Bradycardia occurred more frequently in chronic heart failure patients (11%) than hypertensive patients (1%) at doses of 20 to 40 mg.</p><p></p><p>Aggravation of cardiac failure occurred in 19% of patients with chronic heart failure compared to 21.3% of placebo-treated patients in the SENIORS (Study on the Effects of Nebivolol Interventions on Outcomes and Rehospitalizations in Seniors with heart failure; n = 2128; median age = 75.2 years).  Heart failure occurred in 0.1% to 1% of hypertensive patients.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Dizziness (up to 11%)</p><p><b>Common</b> (1% to 10%): Headache, paresthesia, somnolence, hypoesthesia</p><p><b>Uncommon</b> (0.1% to 1%): Vertigo</p><p><b>Very rare</b> (less than 0.01%): Syncope<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dyspnea, exacerbated dyspnea, common cold, coughing, bronchitis, pharyngitis</p><p><b>Uncommon</b> (0.1% to 1%): Bronchospasm</p><p><b>Postmarketing reports</b>: Acute pulmonary edema<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Increased sweating</p><p><b>Uncommon</b> (0.1% to 1%): Pruritus, erythematous rash</p><p><b>Very rare</b> (less than 0.01%): Psoriasis aggravated </p><p><b>Frequency not reported</b>: Angioneurotic edema, urticaria</p><p><b>Postmarketing reports</b>: Rash, skin disorders<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia, arthrosis, back pain<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, diarrhea, nausea </p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, flatulence, vomiting </p><p><b>Frequency not reported</b>: Abdominal pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Tiredness, drug intolerance, pain, injury, fatigue</p><p><b>Frequency not reported</b>: Asthenia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Nervousness </p><p><b>Uncommon</b> (0.1% to 1%): Nightmares, depression, insomnia, anxiety<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Impotence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Impaired vision<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Decreased platelet count</p><p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Frequency not reported</b>: Increased BUN</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Hypercholesterolemia, hyperuricemia, increased uric acid, increased triglycerides, decreased HDL cholesterol<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal hepatic function (e.g., increased AST, ALT, and bilirubin)<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity (e.g., allergic vasculitis, angioedema, urticaria)<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Bystolic (nebivolol)." Forest Pharmaceuticals, St. Louis, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about nebivolol</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>221 Reviews</li>
<li>Drug class: cardioselective beta blockers</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nebivolol &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
<li>Mitral Valve Prolapse</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>